FGF23/FGFR4-mediated left ventricular hypertrophy is reversible

MLA

Karla Schramm, et al. “FGF23/FGFR4-Mediated Left Ventricular Hypertrophy Is Reversible.” Scientific Reports, vol. 7, no. 1, May 2017, pp. 1–12. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e7e2c1769e03ae58ebdbf7c1c9078571&authtype=sso&custid=ns315887.

APA

Karla Schramm, Christopher Yanucil, Neerupma Silswal, Michael J. Wacker, Jörg Stypmann, Matt Hendrix, Brian Czaya, Saurav Singh, Myles Wolf, Giovana Seno Di Marco, Marcus Brand, Christian Faul, Sven Hermann, & Alexander Grabner. (2017). FGF23/FGFR4-mediated left ventricular hypertrophy is reversible. Scientific Reports, 7(1), 1–12.

Chicago

Karla Schramm, Christopher Yanucil, Neerupma Silswal, Michael J. Wacker, Jörg Stypmann, Matt Hendrix, Brian Czaya, et al. 2017. “FGF23/FGFR4-Mediated Left Ventricular Hypertrophy Is Reversible.” Scientific Reports 7 (1): 1–12. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e7e2c1769e03ae58ebdbf7c1c9078571&authtype=sso&custid=ns315887.